Phytochemical Investigation and Anti-COVID Screening of Compounds from Bischofia javanica Leaves

Abstract

The global impact of the coronavirus pandemic on human health, economy, and society has been profound. In this context, the search for potent anti-viral drugs has become an urgent necessity. Bischofia javanica, a plant species of the family Phyllanthaceae, has a rich traditional history of treating chronic conditions such as inflammation, tuberculosis, ulcers, fractures, and eczema. Furthermore, previous research studies have reported its potential secondary metabolite activities, such as anti-diabetic, anti-venom, sedative, and anti-cancer activities. This study, therefore, was aimed at isolating, determining the structure, and evaluating the bioactivities of Bischofia javanica leaves, including their potential as anti-COVID, antiinflammatory, and cytotoxic agents, offering a ray of hope in the fight against the pandemic